DEPO Related Analyst Ratings
-
WallachBeth Capital Downgrades DepoMed Inc (DEPO) to Hold
-
Janney Montgomery Scott Starts DepoMed Inc (DEPO) at Buy
-
Janney Montgomery Scott Starts DepoMed Inc (DEPO) at Buy
-
WallachBeth Capital Starts DepoMed Inc (DEPO) at Buy
-
Auriga Reiterates a 'Buy' on DepoMed (DEPO); Q1 Beats...Taking Proactive Approach
-
Auriga Maintains a 'Buy' on DepoMed Inc (DEPO); Plans of NDA for Serada
-
Auriga Maintains a 'Buy' on DepoMed (DEPO); Janumet XR Launch should boost Royalty Income in 2012
-
Auriga Maintains a 'Buy' on DepoMed (DEPO); Actavis Filed Paragraph IV Certification; No Generic Expected Any Time Soon
-
ThinkEquity Starts DepoMed Inc (DEPO) at Buy
-
JMP Securities Starts DepoMed Inc (DEPO) at Market Outperform
-
Auriga Starts DepoMed (DEPO) at Buy; Proven Drug Delivery Technology
-
Roth Capital Upgrades DepoMed Inc (DEPO) to Buy
-
Capstone Investments Starts DepoMed Inc (DEPO) at Buy
-
Roth Capital Downgrades DepoMed Inc (DEPO) to Neutral
-
Canaccord Genuity Morning Coffee on DepoMed (DEPO): Not To Be Confused With The Chainsaw Vendor
-
Merriman Curhan Ford Downgrades DepoMed (DEPO) to Neutral
-
Merriman Curhan Ford Downgrades Depomed, Inc. (DEPO) to Neutral
-
Caris & Co Initiates Coverage on DepoMed (DEPO) with a Buy
-
Merriman Curhan Ford Maintains a 'Buy' on Depomed (DEPO); Lowers PT Range
-
Merriman Curhan Ford Said DepoMed's (DEPO) Lack of Wall Street Attention Is About to Change
-
Merriman Curhan Ford Initiates Coverage on Depomed (DEPO) with a Buy
-
Roth Capital Initiates Coverage on Depomed (DEPO) with a Buy
-
Thomas Weisel Downgrades Depomed (DEPO)
-
Matrix USA Starts DepoMed Inc (DEPO) at Strong Sell
-
W.R. Hambrecht Initiates Coverage on DepoMed (DEPO) with a Buy Rating
-
Oppenheimer Starts DEPO at Buy
-
Merriman Curhan Starts DEPO at Buy
-
Banc of America Starts DEPO at Buy
Back to DEPO Stock Lookup
